
Aganitha provides AI-powered computational science to speed up drug discovery and development. The company combines high-throughput experimental approaches with deep learning-based generative models, powered by Agentic AI and Generative AI, along with computational biology and computational chemistry. It targets biopharma research needs such as target discovery, small molecule and antibody engineering, RNA and gene therapies, and CMC, serving global pharmaceutical partners. A multi-domain team leverages a reference architecture and computational platform to deliver rapid, high-quality solutions and scalable workflows for R&D across programs and time.

Aganitha provides AI-powered computational science to speed up drug discovery and development. The company combines high-throughput experimental approaches with deep learning-based generative models, powered by Agentic AI and Generative AI, along with computational biology and computational chemistry. It targets biopharma research needs such as target discovery, small molecule and antibody engineering, RNA and gene therapies, and CMC, serving global pharmaceutical partners. A multi-domain team leverages a reference architecture and computational platform to deliver rapid, high-quality solutions and scalable workflows for R&D across programs and time.